A Proposed Collaboration Against Big Tobacco: Common Ground Between the Vaping and Public Health Community in the United States

Nicotine and Tobacco Research

Volumn 18, Issue 5, 2016, Pages 730-736

  Wagener, Theodore ^a,b   Meier, Ellen ^a,c   Tackett, Alayna ^a,c   Matheny, James ^a   Pechacek, Terry ^d  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c OKLAHOMA STATE UNIVERSITY   (United States)

^d GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMMUNITY; ELECTRONIC CIGARETTE; GOVERNMENT REGULATION; HARM REDUCTION; HUMAN; NICOTINE REPLACEMENT THERAPY; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH COMMUNITY; PUBLIC HEALTH SERVICE; SMOKING CESSATION; SMOKING REGULATION; TOBACCO; UNITED STATES; VAPING COMMUNITY; ADULT; ADVERSE EFFECTS; EPIDEMIOLOGY; FEMALE; HEALTH EDUCATION; INTERSECTORAL COLLABORATION; MALE; PREVENTION AND CONTROL; PROCEDURES; PUBLIC HEALTH; SMOKING; TOBACCO INDUSTRY;

ADULT; ELECTRONIC CIGARETTES; FEMALE; HEALTH EDUCATION; HUMANS; INTERSECTORAL COLLABORATION; MALE; PUBLIC HEALTH; SMOKING; TOBACCO INDUSTRY; UNITED STATES;

EID: 84964956059     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntv241     Document Type: Note

References (72)

1. Wagener TL, Siegel M, Borrelli B. Electronic cigarettes: achieving a balanced perspective. Addiction. 2012;107(9):1545-1548. doi:10.1111/j.1360-0443.2012.03826.x.
2. Benowitz NL. Emerging nicotine delivery products. Implications for public health. Ann Am Thorac Soc. 2014;11(2):231-235. doi:10.1513/ AnnalsATS.201312-433PS.
3. Cobb NK, Abrams DB. The FDA, e-cigarettes, and the demise of combusted tobacco. N Engl J Med. 2014;371(16):1469-1471. doi:10.1056/ NEJMp1408448.
4. Henningfield JE. The tobacco endgame: it's all about behavior. Prev Med. 2014;68:11-16. doi:10.1016/j.ypmed.2014.09.003.
5. Fagerstrom KO, Bridgman K. Tobacco harm reduction: the need for new products that can compete with cigarettes. Addict Behav. 2014;39(3):507- 511. doi:10.1016/j.addbeh.2013.11.002.
6. Oklahoma State Senate. Study youth access to harm reduction products. OkDocs Class# L1310.7 I61s 13-522014. 2014. http://digitalprairie. ok.gov/cdm/ref/collection/stgovpub/id/382146. Accessed August 20, 2015.
7. Caponnetto P, Saitta D, Sweanor D, Polosa R. What to consider when regulating electronic cigarettes: pros, cons and unintended consequences. Int J Drug Policy. 2015;26(6):554-559. doi:http://dx.doi.org/10.1016/j. drugpo.2015.03.001.
8. McNeill A, Brose L, Calder R, Hitchman SC, Hajek P, McRobbie H. E-cigarettes: An Evidence Update. London, United Kingdom: Public Health England 2015.
9. Kalkhoran S, Glantz SA. Modeling the health effects of expanding e-cigarette sales in the United States and United Kingdom: a Monte Carlo Analysis. JAMA Intern Med. 2015;175(10):1671-1680. doi:10.1001/ jamainternmed.2015.4209.
10. Dutra LM, Glantz SA. High international electronic cigarette use among never smoker adolescents. J Adolesc Health. 2014;55(5):595-597. doi:10.1016/j.jadohealth.2014.08.010.
11. West R, Brown J. Electronic cigarettes: fact and faction. Br J Gen Pract. 2014;64(626):442-443. doi:10.3399/bjgp14X681253.
12. Hitchman SC, McNeill A, Brose LS. Electronic cigarettes: time for an accurate and evidence-based debate. Addiction. 2014;109(6):867-868. doi:10.1111/add.12550.
13. McNeill A, Brose LS, Calder R, Hitchman SC, Hajek P, McRobbie H. E-cigarettes: the need for clear communication on relative risks. Lancet. 2015;386(10000):1237. doi:10.1016/S0140-6736(15)00079-3.
14. Richtel M. Where vapor comes sweeping down the plain: e-cigarettes take hold in Oklahoma. New York Times. April 26, 2014.
15. Camilleri L. Philip Morris International Inc. Annual Meeting of Shareholders; May 2015; New York, NY.
16. Parascandola M. Lessons from the history of tobacco harm reduction: the National Cancer Institute's Smoking and Health Program and the "less hazardous cigarette". Nicotine Tob Res. 2005;7(5):779-789. doi:10.1080/14622200500262584.
17. Gray N. Reflections on the saga of tar content: why did we measure the wrong thing? Tob Control. 2000;9(1):90-94.
18. Ng M, Freeman MK, Fleming TD, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA. 2014;311(2):183-192. doi:10.1001/jama.2013.284692.
19. Biener L, Nyman AL, Stepanov I, Hatsukami D. Public education about the relative harm of tobacco products: an intervention for tobacco control professionals. Tob Control. 2014;23(5):385-388. doi:10.1136/ tobaccocontrol-2012-050814.
20. Cline T. Dr. Terry Cline: State health commissioner says e-cigarettes need study and regulation. 2013. www.tulsaworld.com/opinion/readersforum/ dr-terry-cline-state-health-commissioner-says-e-cigarettes-need/article_ aa2a9c9e-17ce-534d-856c-b50c953dfd7d.html. Accessed August 20, 2015.
21. Pisinger C. Why public health people are more worried than excited over e-cigarettes. BMC Medicine. 2014;12(1):226. doi:10.1186/ s12916-014-0226-y.
22. Cheney MK, Gowin M, Wann TF. Vapor store owner beliefs and messages to customers [published online ahead of print June 25, 2015]. Nicotine Tob Res. doi:10.1093/ntr/ntv129.
23. Fagerstrom K, Etter J-F, Unger JB. E-cigarettes: a disruptive technology that revolutionizes our field? Nicotine Tob Res. 2015;17(2):125-126. doi:10.1093/ntr/ntu240.
24. Health CDoP. State Health Officer Issues Health Advisory and New E-Cigarette Report. 2015. www.cdph.ca.gov/Pages/NR15-12.aspx. Accessed January 28, 2015.
25. Pisinger C, Dossing M. A systematic review of health effects of electronic cigarettes. Prev Med. 2014;69:248-260. doi:10.1016/j. ypmed.2014.10.009.
26. McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P. Electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst Rev. 2014;12:CD010216. doi:10.1002/14651858.CD010216.pub2.
27. Hajek P, Etter JF, Benowitz N, Eissenberg T, McRobbie H. Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction. 2014;109(11):1801-1810. doi:10.1111/ add.12659.
28. Hitchman SC, Brose LS, Brown J, Robson D, McNeill A. Associations between e-cigarette type, frequency of use, and quitting smoking: findings from a longitudinal online panel survey in Great Britain. Nicotine Tob Res. 2015;17(10):1187-1194. doi:10.1093/ntr/ntv078.
29. Adriaens K, Van Gucht D, Declerck P, Baeyens F. Effectiveness of the electronic cigarette: an eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints. Int J Environ Res Public Health. 2014;11(11):11220-11248. doi:10.3390/ ijerph111111220.
30. CDC Director on Antibiotics, Influenza, and E-Cigarettes. 2013. www. medscape.com/viewarticle/811616. Accessed August 20, 2015.
31. Meier EM, Tackett AP, Miller MB, Grant DM, Wagener TL. Which nicotine products are gateways to regular use? First-tried tobacco and current use in college students. Am J Prev Med. 2015;48(1)(suppl 1):S86-93. doi:10.1016/j.amepre.2014.09.018.
32. Wagener TL, Meier E, Hale JJ, et al. Pilot investigation of changes in readiness and confidence to quit smoking after E-cigarette experimentation and 1 week of use. Nicotine Tob Res. 2014;16(1):108-114. doi:10.1093/ntr/ ntt138.
33. SAMHSA. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. 2014. www.samhsa.gov/data/sites/ default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013. pdf. Accessed February 15, 2015.
34. Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf. 2014;5(2):67-86. doi:10.1177/2042098614524430.
35. Nutt DJ, Phillips LD, Balfour D, et al. Estimating the harms of nicotine- containing products using the MCDA approach. Eur Addict Res. 2014;20(5):218-225. doi:10.1159/000360220.
36. Czogala J, Goniewicz ML, Fidelus B, Zielinska-Danch W, Travers MJ, Sobczak A. Secondhand exposure to vapors from electronic cigarettes. Nicotine Tob Res. 2014;16(6):655-662. doi:10.1093/ntr/ntt203.
37. Bullen C, McRobbie H, Thornley S, Glover M, Lin R, Laugesen M. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised crossover trial. Tob Control. 2010;19(2):98-103.
38. Bullen C, Howe C, Laugesen M, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013;382(9905):1629- 1637. doi:10.1016/S0140-6736(13)61842-5.
39. Cahn Z, Siegel M. Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes? J Public Health Policy. 2011;32(1):16-31. doi:10.1057/jphp.2010.41.
40. Ross G. The Anti-E-Cigarette Conspiracy: The National Review Online. www.nationalreview.com/article/373157/anti-e-cigarette-conspiracy- gilbert-ross. Accessed February 15, 2015.
41. Administration USFaD. Alphabetical List of Select Committee on Genderally Recongized as Safe Substances. 2013. www.fda.gov/Food/ IngredientsPackagingLabeling/GRAS/SCOGS/ucm084104.htm. Accessed March 19, 2014.
42. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23(2):133-139. doi:10.1136/tobaccocontrol-2012-050859.
43. Farsalinos KE, Spyrou A, Tsimopoulou K, Stefopoulos C, Romagna G, Voudris V. Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci Rep. 2014;4:4133. doi:10.1038/srep04133.
44. Talih S, Balhas Z, Salman R, Karaoghlanian N, Shihadeh A. "Direct Dripping": a high-temperature, high-formaldehyde emission electronic cigarette use method [published online ahead of print April 11, 2015]. Nicotine Tob Res. doi:10.1093/ntr/ntv080.
45. Kosmider L, Sobczak A, Fik M, Knysak J, Zaciera M, Kurek J, et al. Carbonyl compounds in electronic cigarette vapors-effects of nicotine solvent and battery output voltage. Nicotine Tob Res. 2014;16(10):1319- 1326. doi:10.1093/ntr/ntu078.
46. Jensen RP, Luo W, Pankow JF, Strongin RM, Peyton DH. Hidden formaldehyde in e-cigarette aerosols. N Engl J Med. 2015;372(4):392-394. doi:10.1056/NEJMc1413069.
47. Farsalinos KE, Voudris V, Poulas K. E-cigarettes generate high levels of aldehydes only in 'dry puff' conditions. Addiction. 2015;110(8):1352- 1356. doi:10.1111/add.12942.
48. Grana R, Benowitz N, Glantz SA. E-cigarettes: a scientific review. Circulation. 2014;129(19):1972-1986. doi:10.1161/ CIRCULATIONAHA.114.007667.
49. Brandon TH, Goniewicz ML, Hanna NH, et al. Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology. J Clin Oncol. 2015;33(8):952-963. doi:10.1200/jco.2014.59.4465.
50. Schraufnagel DE, Blasi F, Drummond MB, et al. Electronic cigarettes. A position statement of the forum of international respiratory societies. Am J Respir Crit Care Med. 2014;190(6):611-618. doi:10.1164/ rccm.201407-1198PP.
51. Chen I-L, Husten CG. Introduction to tobacco control supplement. Tob Control. 2014;23(suppl 2):ii1-ii3. doi:10.1136/ tobaccocontrol-2013-051504.
52. E-cigarettes: Public Health England's evidence-based confusion. Lancet. 2015;386(9996):829. doi:http://dx.doi.org/10.1016/S0140-6736(15)00042-2.
53. England PH. E-cigarette Commentaries. 2015. www.clivebates. com/?p=2908. Accessed March 10, 2015.
54. Cartwright S. MSc Report: British American Tobacco's Approaches to Harm Reduction and Smokeless Tobacco. London, United Kingdom: LSHTM; 2007.
55. Biener L, Bogen K, Connolly G. Impact of corrective health information on consumers' perceptions of "reduced exposure" tobacco products. Tob Control. 2007;16(5):306-311.
56. Borgida E, Loken B, Williams AL, Vitriol J, Stepanov I, Hatsukami D. Assessing constituent levels in smokeless tobacco products: a new approach to engaging and educating the public. Nicotine Tob Res. 2015;17(11):1354-1361. doi:10.1093/ntr/ntv007.
57. Zeller M, Hatsukami D. The strategic dialogue on tobacco harm reduction: a vision and blueprint for action in the US. Tob Control. 2009;18(4):324-332.
58. Cardinale A, Nastrucci C, Cesario A, Russo P. Nicotine: specific role in angiogenesis, proliferation and apoptosis. Crit Rev Toxicol. 2012;42(1):68-89. doi:10.3109/10408444.2011.623150.
59. Grando SA. Connections of nicotine to cancer. Nat Rev Cancer. 2014;14(6):419-429. doi:10.1038/nrc3725.
60. Nordenvall C, Nilsson PJ, Ye W, Andersson TM, Nyren O. Tobacco use and cancer survival: a cohort study of 40,230 Swedish male construction workers with incident cancer. Int J Cancer. 2013;132(1):155-161. doi:10.1002/ijc.27587.
61. Steinberg MB, Zimmermann MH, Delnevo CD, et al. E-cigarette versus nicotine inhaler: comparing the perceptions and experiences of inhaled nicotine devices. J Gen Intern Med. 2014;29(11):1444-1450. doi:10.1007/ s11606-014-2889-7.
62. Hart C, Gruer L, Bauld L. Does smoking reduction in midlife reduce mortality risk? Results of 2 long-term prospective cohort studies of men and women in Scotland. Am J Epidemiol. 2013;178(5):770-779. doi:10.1093/ aje/kwt038.
63. Song YM, Sung J, Cho HJ. Reduction and cessation of cigarette smoking and risk of cancer: a cohort study of Korean men. J Clin Oncol. 2008;26(31):5101-5106. doi:10.1200/JCO.2008.17.0498.
64. American Lung Association. Tobacco Policy Project. State Legislated Actions on Tobacco Issues (SLATI). 2014. http://slati.lung.org. Accessed October 5, 2015.
65. Colard S, O'Connell G, Verron T, Cahours X, Pritchard JD. Electronic cigarettes and indoor air quality: a simple approach to modeling potential bystander exposures to nicotine. Int J Environ Res Public Health. 2015;12(1):282-299. doi:10.3390/ijerph120100282.
66. Tayyarah R, Long GA. Comparison of select analytes in aerosol from e-cigarettes with smoke from conventional cigarettes and with ambient air. Regul Toxicol Pharmacol. 2014;70(3):704-710. doi:10.1016/j. yrtph.2014.10.010.
67. Long GA. Comparison of select analytes in exhaled aerosol from e-cigarettes with exhaled smoke from a conventional cigarette and exhaled breaths. Int J Environ Res Public Health. 2014;11(11):11177-11191. doi:10.3390/ijerph111111177.
68. Herzog B. "Tobacco Talk" -- Q4 U.S. Vapor Retailer Survey. Wells Fargo Securities. 2015:1-18.
69. Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, Spyrou A, Voudris V. Impact of flavour variability on electronic cigarette use experience: an internet survey. Int J Environ Res Public Health. 2013;10(12):7272-7282. doi:10.3390/ijerph10127272.
70. Chaloupka FJ, Sweanor D, Warner KE. Differential taxes for differential risks-toward reduced harm from nicotine-yielding products. N Engl J Med. 2015;373(7):594-597. doi:10.1056/NEJMp1505710.
71. Donny EC, Denlinger RL, Tidey JW, et al. Randomized trial of reducednicotine standards for cigarettes. N Engl J Med. 2015;373(14):1340- 1349. doi:10.1056/NEJMsa1502403.
72. Fiore M, Baker T. Reduced-nicotine cigarettes-a promising regulatory pathway. N Engl J Med. 2015;373(14):1289-1291. doi:10.1056/ NEJMp1509510.